MENU

Lab notes: Onconova completes $21M stock sale; Waypoint gets $1.7M investment

Three Philadelphia-area drug developers expanded their senior management teams.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
TOP
Email a Story